Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Metachronous intraductal papillary mucinous neoplasms disseminate via the pancreatic duct following resection

Modern Pathology volume 33, pages971–980(2020)Cite this article

Subjects

Abstract

Metachronous development of intraductal papillary mucinous neoplasms in the remnant pancreas following resection is a significant clinical burden. Our aim was to characterize the clinicopathological and molecular features of the patients with metachronous tumor development to identify predictive factors and the possible route(s) of dissemination. Seventy-four patients who underwent resection of intraductal papillary mucinous neoplasms with no invasive compartment or associated carcinoma were retrospectively analyzed. In patients with metachronous tumor development, targeted sequencing of 18 genes associated with pancreatic tumorigenesis and immunohistochemical detection of four proteins (p53, SMAD4, p16, and β-catenin) were performed on both primary and metachronous tumors. The distributions of microscopic neoplastic lesions were examined at surgical margins and in apparently normal tissue apart from the primary tumor. During the median follow-up period of 52 months, 9 patients (12%) developed metachronous tumors in the remnant pancreas. Primary tumors located in the body/tail of the pancreas (odds ratio, 15; 95% confidence interval, 1.6–131) and of the pancreatobiliary type (odds ratio, 6.1; 95% confidence interval, 1.1–35.7) were identified as significant risk factors for subsequent metachronous tumor development. Eight of the nine patients shared molecular aberrations between their primary and metachronous tumors, suggesting migrations from the primary tumor to the pancreatic duct as the cause of metachronous tumor development. Our data suggest that these post-resection metachronous tumors develop by skip dissemination of the primary tumor, potentially via the pancreatic duct. The development of strategies to better predict and prevent this form of tumor progression is necessary.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

Rent or Buy

All prices are NET prices.

Fig. 1
Fig. 2
Fig. 3

References

  1. 1.

    Patra KC, Bardeesy N, Mizukami Y. Diversity of precursor lesions for pancreatic cancer: the genetics and biology of intraductal papillary mucinous neoplasm. Clin Transl Gastroenterol. 2017;8:e86.

    Article  Google Scholar 

  2. 2.

    Klöppel G, Basturk O, Schlitter AM, Konukiewitz B, Esposito I. Intraductal neoplasms of the pancreas. Semin Diagn Pathol. 2014;31:452–66.

    Article  Google Scholar 

  3. 3.

    Griffin JF, Poruk KE, Wolfgang CL. Is it time to expand the role of total pancreatectomy for IPMN? Dig Surg. 2016;33:335–42.

    Article  Google Scholar 

  4. 4.

    Waters JA, Schnelldorfer T, Aguilar-Saavedra JR, Chen JH, Yiannoutsos CT, Lillemoe KD, et al. Survival after resection for invasive intraductal papillary mucinous neoplasm and for pancreatic adenocarcinoma: a multi-institutional comparison according to American Joint Committee on Cancer Stage. J Am Coll Surg. 2011;213:275–83.

    Article  Google Scholar 

  5. 5.

    Dhar VK, Merchant NB, Patel SH, Edwards MJ, Wima K, Imbus J, et al. Does surgical margin impact recurrence in noninvasive intraductal papillary mucinous neoplasms? A multi-institutional study. Ann Surg. 2018;268:469–78.

    Article  Google Scholar 

  6. 6.

    Frankel TL, LaFemina J, Bamboat ZM, et al. Dysplasia at the surgical margin is associated with recurrence after resection of non-invasive intraductal papillary mucinous neoplasms. HPB (Oxf). 2013;15:814–21.

    Article  Google Scholar 

  7. 7.

    Kang MJ, Jang JY, Lee KB, D’Angelica MI, DeMatteo RP, Fong Y, et al. Long-term prospective cohort study of patients undergoing pancreatectomy for intraductal papillary mucinous neoplasm of the pancreas: implications for postoperative surveillance. Ann Surg. 2014;260:356–63.

    Article  Google Scholar 

  8. 8.

    Marchegiani G, Mino-Kenudson M, Ferrone CR, Morales-Oyarvide V, Warshaw AL, Lillemoe KD, et al. Patterns of recurrence after resection of IPMN: who, when, and how? Ann Surg. 2015;262:1108–14.

    Article  Google Scholar 

  9. 9.

    He J, Cameron JL, Ahuja N, Makary MA, Hirose K, Choti MA, et al. Is it necessary to follow patients after resection of a benign pancreatic intraductal papillary mucinous neoplasm? J Am Coll Surg. 2013;216:657–67.

    Article  Google Scholar 

  10. 10.

    Izawa T, Obara T, Tanno S, Mizukami Y, Yanagawa N, Kohgo Y. Clonality and field cancerization in intraductal papillary-mucinous tumors of the pancreas. Cancer. 2001;92:1807–17.

    CAS  Article  Google Scholar 

  11. 11.

    Matthaei H, Norris AL, Tsiatis AC, Olino K, Hong SM, dal Molin M, et al. Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 2012;255:326–33.

    Article  Google Scholar 

  12. 12.

    Tamura K, Ohtsuka T, Matsunaga T, Kimura H, Watanabe Y, Ideno N, et al. Assessment of clonality of multisegmental main duct intraductal papillary mucinous neoplasms of the pancreas based on GNAS mutation analysis. Surgery. 2015;157:277–84.

    Article  Google Scholar 

  13. 13.

    Tamura K, Ohtsuka T, Ideno N, Aso T, Shindo K, Aishima S, et al. Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: a retrospective review. Ann Surg. 2014;259:360–8.

    Article  Google Scholar 

  14. 14.

    Date K, Ohtsuka T, Fujimoto T, Tamura K, Kimura H, Matsunaga T, et al. Molecular evidence for monoclonal skip progression in main duct intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 2017;265:969–77.

    Article  Google Scholar 

  15. 15.

    Habuchi T, Takahashi R, Yamada H, Kakehi Y, Sugiyama T, Yoshida O. Metachronous multifocal development of urothelial cancers by intraluminal seeding. Lancet. 1993;342:1087–8.

    CAS  Article  Google Scholar 

  16. 16.

    Morales-Oyarvide V, Mino-Kenudson M. Tumor islands and spread through air spaces: distinct patterns of invasion in lung adenocarcinoma. Pathol Int. 2016;66:1–7.

    Article  Google Scholar 

  17. 17.

    Sanli O, Dobruch J, Knowles MA, Burger M, Alemozaffar M, Nielsen ME, et al. Bladder cancer. Nat Rev Dis Prim. 2017;3:17022.

    Article  Google Scholar 

  18. 18.

    Kim MY, Oskarsson T, Acharyya S, Nguyen DX, Zhang XH, Norton L, et al. Tumor self-seeding by circulating cancer cells. Cell. 2009;139:1315–26.

    Article  Google Scholar 

  19. 19.

    Rhim AD, Mirek ET, Aiello NM, Maitra A, Bailey JM, McAllister F, et al. EMT and dissemination precede pancreatic tumor formation. Cell. 2012;148:349–61.

    CAS  Article  Google Scholar 

  20. 20.

    Pandya P, Orgaz JL, Sanz-Moreno V. Modes of invasion during tumour dissemination. Mol Oncol. 2017;11:5–27.

    Article  Google Scholar 

  21. 21.

    Makohon-Moore AP, Matsukuma K, Zhang M, Reiter JG, Gerold JM, Jiao Y, et al. Precancerous neoplastic cells can move through the pancreatic ductal system. Nature. 2018;561:201–5.

    CAS  Article  Google Scholar 

  22. 22.

    Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B, et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature. 2010;467:1114–7.

    CAS  Article  Google Scholar 

  23. 23.

    Hosseini H, Obradovic MM, Hoffmann M, Harper KL, Sosa MS, Werner-Klein M, et al. Early dissemination seeds metastasis in breast cancer. Nature. 2016;540:552–8.

    CAS  Article  Google Scholar 

  24. 24.

    Omori Y, Ono Y, Tanino M, Karasaki H, Yamaguchi H, Furukawa T, et al. Pathways of progression from intraductal papillary mucinous neoplasm to pancreatic ductal adenocarcinoma based on molecular features. Gastroenterology. 2019;156:647–61.e2.

    CAS  Article  Google Scholar 

  25. 25.

    Felsenstein M, Noe M, Masica DL, Hosoda W, Chianchiano P, Fischer CG, et al. IPMNs with co-occurring invasive cancers: neighbours but not always relatives. Gut. 2018;67:1652–62.

    CAS  Article  Google Scholar 

  26. 26.

    Tanaka M, Fernandez-Del Castillo C, Kamisawa T, Jang JY, Levy P, Ohtsuka T, et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology. 2017;17:738–53.

    Article  Google Scholar 

  27. 27.

    Yamaguchi K, Kanemitsu S, Hatori T, Maguchi H, Shimizu Y, Tada M, et al. Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN. Pancreas. 2011;40:571–80.

    Article  Google Scholar 

  28. 28.

    Basturk O, Hong SM, Wood LD, Adsay NV, Albores-Saavedra J, Biankin AV, et al. A revised classification system and recommendations from the Baltimore consensus meeting for neoplastic precursor lesions in the pancreas. Am J Surg Pathol. 2015;39:1730–41.

    Article  Google Scholar 

  29. 29.

    Qian ZR, Rubinson DA, Nowak JA, Morales-Oyarvide V, Dunne RF, Kozak MM, et al. Association of alterations in main driver genes with outcomes of patients with resected pancreatic ductal adenocarcinoma. JAMA Oncol. 2018;4:e173420.

    Article  Google Scholar 

  30. 30.

    Yachida S, White CM, Naito Y, Zhong Y, Brosnan JA, Macgregor-Das AM, et al. Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivors. Clin Cancer Res. 2012;18:6339–47.

    CAS  Article  Google Scholar 

  31. 31.

    Sato N, Rosty C, Jansen M, Fukushima N, Ueki T, Yeo CJ, et al. STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol. 2001;159:2017–22.

    CAS  Article  Google Scholar 

  32. 32.

    Sethi V, Giri B, Saluja A, Dudeja V. Insights into the pathogenesis of pancreatic cystic neoplasms. Dig Dis Sci. 2017;62:1778–86.

    CAS  Article  Google Scholar 

  33. 33.

    Pea A, Yu J, Rezaee N, Luchini C, He J, Dal Molin M, et al. Targeted DNA sequencing reveals patterns of local progression in the pancreatic remnant following resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Ann Surg. 2017;266:133–41.

    Article  Google Scholar 

  34. 34.

    Eguchi H, Ishikawa O, Ohigashi H, Sasaki Y, Yamada T, Nakaizumi A, et al. Role of intraoperative cytology combined with histology in detecting continuous and skip type intraductal cancer existence for intraductal papillary mucinous carcinoma of the pancreas. Cancer. 2006;107:2567–75.

    Article  Google Scholar 

  35. 35.

    Imai K, Karasaki H, Ono Y, Sasajima J, Chiba S, Funakoshi H, et al. Metachronous pancreatic cancer originating from disseminated founder pancreatic intraductal neoplasias (PanINs). J Pathol Clin Res. 2015;1:76–82.

    CAS  Article  Google Scholar 

  36. 36.

    Luchini C, Pea A, Yu J, He J, Salvia R, Riva G, et al. Pancreatic cancer arising in the remnant pancreas is not always a relapse of the preceding primary. Mod Pathol. 2019;32:659–65.

    Article  Google Scholar 

  37. 37.

    Furukawa T, Hatori T, Fujita I, Yamamoto M, Kobayashi M, Ohike N, et al. Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas. Gut. 2011;60:509–16.

    Article  Google Scholar 

  38. 38.

    Karasaki H, Mizukami Y, Tokusashi Y, Koizumi K, Ishizaki A, Imai K, et al. Localization of the most severely dysplastic/invasive lesions and mucin phenotypes in intraductal papillary mucinous neoplasm of the pancreas. Pancreas. 2011;40:588–94.

    Article  Google Scholar 

  39. 39.

    Kopp JL, Dubois CL, Schaeffer DF, Samani A, Taghizadeh F, Cowan RW, et al. Loss of Pten and activation of Kras synergistically induce formation of intraductal papillary mucinous neoplasia from pancreatic ductal cells in mice. Gastroenterology. 2018;154:1509–23.e5.

    CAS  Article  Google Scholar 

Download references

Acknowledgements

This work was supported by JSPS KAKENHI grant number 17K09472, the Suzuken Memorial Foundation, and the Suhara Memorial Foundation, all to YM. We thank Takuya Sugimura (Teine-Keijinkai Hospital) for tissue sample preparation, and Munehiko Ogata and Atsuko Sumi (Sapporo Higashi Tokushukai Hospital) for technical support in the genetic analyses. We thank the members of the Center for Gastroenterology at Teine-Keijinkai Hospital and laboratory staff of the Institute of Biomedical Research at Sapporo Higashi Tokushukai Hospital for their helpful suggestions. We thank Helena Akiko Popiel for editorial review of the manuscript. We thank Editage (www.editage.jp) for English language editing.

Author information

Affiliations

  1. Center for Gastroenterology, Teine-Keijinkai Hospital, Sapporo, Japan

    Kazumasa Nagai, Toshifumi Kin, Kei Yane, Kuniyuki Takahashi, Tsuyoshi Hayashi, Hiroyuki Maguchi & Akio Katanuma

  2. Department of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan

    Kazumasa Nagai

  3. Institute of Biomedical Research, Sapporo Higashi Tokushukai Hospital, Sapporo, Japan

    Yusuke Mizukami, Yusuke Ono, Ayumu Sugitani & Hidenori Karasaki

  4. Department of Medicine, Asahikawa Medical University, Asahikawa, Japan

    Yusuke Mizukami & Toshikatsu Okumura

  5. Department of Pathology, Teine-Keijinkai Hospital, Sapporo, Japan

    Yuko Omori & Toshiya Shinohara

  6. Department of Investigative Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan

    Yuko Omori & Toru Furukawa

Authors
  1. Kazumasa Nagai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yusuke Mizukami
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yuko Omori
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Toshifumi Kin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kei Yane
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kuniyuki Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yusuke Ono
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ayumu Sugitani
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hidenori Karasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Toshiya Shinohara
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Toru Furukawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Tsuyoshi Hayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Toshikatsu Okumura
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Hiroyuki Maguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Akio Katanuma
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Yusuke Mizukami or Akio Katanuma.

Ethics declarations

Conflict of interest

YM and YO receive funding from Hitachi Hightechnologies Inc. The other authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Nagai, K., Mizukami, Y., Omori, Y. et al. Metachronous intraductal papillary mucinous neoplasms disseminate via the pancreatic duct following resection. Mod Pathol 33, 971–980 (2020). https://doi.org/10.1038/s41379-019-0405-7

Download citation

Further reading

Search

Quick links